“Dihydroisoindolo[2,1-a]quinazoline-5,11-dione derivatives as potent and selective inhibitors targeting hepatitis B virus”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 612–620, Jul. 2015, doi: 10.3329/bjp.v10i3.23264.